Viral Vectors: Gene Therapy and Neuroscience Applications

Front Cover
Michael G. Kaplitt, Arthur D. Loewy
Academic Press, Aug 14, 1995 - Medical - 486 pages
Genetic manipulation of the adult mammalian nervous system is one of the most exciting areas in contemporary neurobiology. The explosive growth of this field has been facilitated by harnessing the power of viruses to transfer genetic material into mammalian cells.
Viral Vectors: Gene Therapy and Neuroscience Applications represents the first comprehensive review of viral vector applications to the nervous system by leaders in virology, molecular neurobiology, neuroanatomy, and developmental neurobiology. It serves both as a source of fundamental information for those newly interested in viral vectors and as a compilation of state-of-the-art technologies and applications for more experienced researchers.
This work provides expert background information on viral systems, and the broad range of applications will help readers appreciate the current and future impact of viral vectors in both clinical and basic neuroscience.

From inside the book

Contents

Chapter 1 Herpes Simplex Virus as a GeneDelivery Vector for the Central Nervous System
1
Chapter 2 Biology of Herpes Simplex Virus HSV Defective Viruses and Development of the Amplicon System
25
Chapter 3 Group C Adenoviruses as Vectors for Gene Therapy
43
Chapter 4 Genetics and Biology of AdenoAssociated Virus
55
Chapter 5 Genetics and Biology of Retroviral Vectors
75
Molecular Analysis of Neuronal Physiology Generation of Genetic Models and Gene Therapy of Neurological Disorders
89
Chapter 7 The Use of Defective Herpes Simplex Virus Amplicon Vectors to Modify Neural Cells and the Nervous System
109
Application to the Reconstruction of Neural Circuits in the Injured Mammalian Brain
119
Chapter 14 Virus VectorMediated Transfer of DrugSensitivity Genes for Experimental Brain Tumor Therapy
239
Chapter 15 Brain Tumor Therapy Using Genetically Engineered ReplicationCompetent Virus
259
Chapter 16 Transfer and Expression of Antioncogenes and Paraneoplastic Genes in Normal and Neoplastic Cells in Vitro and in Viva
275
A Review of the Methodology
293
Chapter 18 Pseudorabies Virus Replication and Assembly in the Rodent Central Nervous System
319
A Transneuronal Tracer for Neuroanatomical Studies
349
Chapter 20 Molecular Properties of Alphaherpesviruses Used in Transneuronal Pathway Tracing
367
Chapter 21 Molecular Analysis of Rabies and Pseudorabies Neurotropism
395

Chapter 9 The Use of Herpes Simplex Virus Vectors for Protection from Necrotic Neuron Death
133
Chapter 10 In Viva Promoter Analysis in the Adult Central Nervous System Using Viral Vectors
157
Potential Therapeutic Applications
173
Chapter 12 Transfer and Expression of Potentially Therapeutic Genes into the Mammalian Central Nervous System in Viva Using AdenoAssociated ...
193
Chapter 13 Genetic Modification of Cells with Retrovirus Vectors for Grafting into the Central Nervous System
211
Chapter 22 The Use of Retroviral Vectors in the Study of Cell Lineage and Migration during the Development of the Mammalian Central Nervous Sy...
411
Immortalization of Neural Cells
435
Index
477
Color Plate Section
487
Copyright

Other editions - View all

Common terms and phrases

Popular passages

Page 233 - Hyman, C, Hofer, M., Barde, Y.-A., Juhasz, M., Yancopoulos, GD, Squinto, SP, and Lindsay, RM (1991). BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230-232.
Page 209 - Graham, FL and van der Eb, AJ (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA.
Page 290 - Gavrieli, Y., Sherman, Y., and Ben-Sasson, SA (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Page 42 - Spaete, RR, and Frenkel, N. (1982). The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector. Cell 30, 295-304.
Page 72 - Shenk, T. (1989) Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol.
Page 232 - Hohn, A., Leibrock, J., Bailey, K., and Barde, Y.-A. (1990) Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344, 339-341.
Page 54 - Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 352, 345-347.
Page 290 - KASTAN, MB, ZHAN, Q., EL-DEIRY, WS, CARRIER, F., JACKS, T., WALSH, WV, PLUNKETT, BS, VOGELSTEIN, B. and FORNACE. AJ, JR. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia.
Page 54 - Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (Lond.), 334: 124-129, 1988.